Taysha Gene Therapies (TSHA) Misses Q1 EPS by 24c
Get Alerts TSHA Hot Sheet
Join SI Premium – FREE
Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 EPS of ($1.31), $0.24 worse than the analyst estimate of ($1.07).
For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Oceanfirst Financial (OCFC) Tops Q1 EPS by 3c
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!